Welcome to our dedicated page for Microchip Technology SEC filings (Ticker: MCHP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Microchip Technology Inc. (NASDAQ: MCHP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed information about its semiconductor business, governance and financial condition. As a Delaware corporation headquartered in Chandler, Arizona, Microchip reports as a public company on the Nasdaq Global Select Market, and its regulatory filings are a primary source for understanding MCHP stock.
On this page, investors can review Microchip’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its role as a broadline supplier of semiconductors serving industrial, automotive, consumer, aerospace and defense, communications and computing markets. These reports typically include discussions of segment performance, risk factors, research and development, and other disclosures relevant to the company’s embedded control and semiconductor portfolio.
Microchip also submits current reports on Form 8-K to announce material events. For example, an 8-K dated November 6, 2025 reports the announcement of results for the second quarter of fiscal year 2026, while an 8-K dated August 20, 2025 details the outcomes of the company’s annual meeting of stockholders, including director elections, auditor ratification and an advisory vote on executive compensation.
Definitive proxy statements on Form DEF 14A provide insight into Microchip’s governance, board composition, executive compensation and stockholder voting procedures. The July 7, 2025 proxy statement outlines the agenda for the 2025 annual meeting, the proposals presented to stockholders and information about how to vote.
Stock Titan’s SEC filings page surfaces these documents as they are made available on EDGAR and can pair them with AI-powered summaries that explain key points, such as changes in guidance, voting results or governance matters. Users can quickly locate Forms 10-K, 10-Q, 8-K and DEF 14A related to Microchip Technology, helping them analyze MCHP’s regulatory history, monitor material events and understand the disclosures that shape the company’s profile in the semiconductor industry.
Microchip Technology executive Joseph R. Krawczyk II, Senior Vice President of Worldwide Client Engagement, reported an open-market sale of 4,400 shares of common stock on February 12, 2026 at an average price of $78.578 per share. After this transaction, he directly beneficially owned 12,781 shares of Microchip Technology common stock.
Microchip Technology executive Mathew B. Bunker reported an open-market sale of company stock. As Senior VP, Operations, he sold 10,000 shares of Microchip Technology common stock on February 12, 2026, at a price of $78.37 per share. Following this transaction, he directly owned 22,522 shares.
An affiliated holder of the issuer has filed a notice of proposed sale under Rule 144 to sell up to 4,400 shares of common stock. The filing lists an aggregate market value of $345,744.08 for the planned sale and indicates 541,135,458 common shares outstanding. The shares to be sold were acquired as restricted stock grants from the issuer on multiple dates between May 2023 and November 2024. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s operations.
Microchip Technology insider Steve Sanghi has filed a Rule 144 notice to sell up to 94,869 shares of common stock through Fidelity Brokerage Services on the NASDAQ. The filing lists an aggregate market value of $7,823,191.83 for these shares and notes an approximate sale date of February 12, 2026.
The shares to be sold were acquired via restricted stock units that vested on multiple dates, including 14,425 shares on November 15, 2023 and 38,930 shares on August 15, 2022. The notice also reports that Sanghi sold 18,509 shares for $1,465,883.19 on January 22, 2026 and 98,814 shares for $7,959,813.55 on January 28, 2026. Microchip had 540,446,834 shares of common stock outstanding at the time referenced.
Microchip Technology Incorporated is issuing $900 million of 0% Convertible Senior Notes due 2030 in a private offering to qualified institutional buyers. An initial $800 million was sold, and initial purchasers fully exercised a $100 million option.
The notes are senior unsecured, mature on February 15, 2030, and are convertible at an initial rate of 9.5993 shares per $1,000 principal (a conversion price of about $104.17 per share, a 40% premium to the $74.41 stock price on February 9, 2026). Microchip will settle conversions with cash up to principal and may use cash, stock, or both for any excess.
Net proceeds were approximately $883.3 million. Microchip used about $68.0 million to buy capped call transactions that are designed to limit dilution, with a cap price of $148.82 per share (a 100% premium to $74.41). The remaining proceeds are intended to repay notes outstanding under its commercial paper program.
Microchip Technology’s chief operating officer Richard J. Simoncic received a grant of 608 restricted stock units on February 6, 2026. Each unit represents the right to receive one share of Microchip common stock. The units vest in full on February 16, 2027, if he continues as a service provider through that date.
After this grant, he holds 608 restricted stock units directly and 155,229 shares of common stock indirectly through a trust.
Microchip Technology Incorporated President, CEO and Chair of the Board Steve Sanghi reported an equity award and his updated shareholdings. On February 6, 2026, he received 5,608 restricted stock units at a price of $0 per unit, held directly.
Each restricted stock unit represents a contingent right to receive one share of Microchip common stock and will vest in full on May 15, 2028, if he remains a service provider through that date. Following this award, he is also reported as indirectly beneficially owning 9,922,319 shares of common stock, with 4,016,447 shares held by The Sanghi Trust and 5,905,872 shares held by The Sanghi Family Limited Partnership.
Microchip Technology Incorporated reported an equity award to senior vice president Joseph R. Krawczyk II. On February 6, 2026, he was granted 349 restricted stock units (RSUs), each representing the right to receive one share of Microchip common stock at no purchase price.
The RSUs will vest in full on February 16, 2027, provided he remains a service provider through that date, and vested shares will be delivered to him upon vesting. After this grant, he directly holds 17,181 shares of common stock and 349 RSUs.
Microchip Technology Incorporated senior vice president of operations Mathew B. Bunker reported a routine equity grant. On February 6, 2026, he received 334 restricted stock units, each representing a contingent right to one share of Microchip common stock at no cash cost.
The 334 restricted stock units will vest in full on February 16, 2027, provided he continues as a service provider through that date. After vesting, the corresponding common shares will be delivered to him. Following this grant, he directly holds 32,522 shares of Microchip common stock.
Microchip Technology Incorporated Senior VP and CFO James Eric Bjornholt received an award of 458 restricted stock units on February 6, 2026. Each unit represents the right to receive one share of Microchip common stock.
The restricted stock units vest in full on February 16, 2027, provided he remains a service provider through that date. After this transaction, he also has 30,089 shares of common stock reported as indirectly owned through a trust.